Pi Pharma at the International Digital Cooperation Forum!
MediaEvent Date : 26-Feb-2025
Pi Pharma Intellegence was privileged to participate in the Digital Cooperation Organization (DCO)'s "Connecting AI Startups to New Markets" panel on Wednesday, February 19, at the Dead Sea, where we delved into a critical discussion on the challenges pharma and health-tech companies encounter when expanding globally.
As Dr. Hazem Al Yakoub, Co-founder of Pi Pharma Intelligence, emphasized, one of the most formidable challenges is navigating diverse legal and regulatory landscapes. Crafting robust data security frameworks, obtaining ISO certifications, and ensuring GDPR compliance in our home market is already a demanding task. Expanding into regions with vastly different requirements exponentially increases the complexity, making it a significant obstacle for startups.
While a unified global standard would be the ultimate solution, the best approach for now is to prioritize markets with aligned regulatory structures, reducing friction and accelerating expansion.
At Pi Pharma, we’re committed to driving AI-powered innovation in the healthcare industry, and discussions like these pave the way for a more seamless, globally connected future.


Strengthening Strategic and Financial Capabilities at Pi Pharma Intelligence
Jul, 2025
At Pi PharmaIntelligence, we believe that data-driven strategy starts with well-equipped teams.
.jpg)
Pi Pharma Intelligence Chosen for WIPO IP Clinic's AI Empowerment Project in Arab Countries
Sep, 2023
Pi Pharma Intelligence Chosen for WIPO IP Clinic's AI Empowerment Project in Arab Countries

Pi Pharma Intelligence Have Participated in The Investor Readiness Program as Part From SURGE Program.
Jun, 2023
Pi Pharma Intelligence Have Participated in The Investor Readiness Program as Part From SURGE Program.